The Phase 2 AURORA clinical trial has met its main goal, demonstrating that treatment with the experimental oral medication bitopertin…
Articles by Marisa Wexler, MS
Treatment with Givlaari (givosiran) was effective for resolving symptoms of hereditary coproporphyria (HCP) in a 47-year-old Japanese woman,…
Outcomes for children with congenital erythropoietic porphyria (CEP) have improved over the last few decades, and babies with CEP…
Treatment with the oral therapy bitopertin substantially increased sunlight tolerance for adults with erythropoietic protoporphyria (EPP) in a Phase…
The International Porphyrias Symposium 2023, where experts discuss the latest research into porphyria, will be held later this…
An unusual case of acute intermittent porphyria (AIP) that was marked by seizures was described in a recent case…
Scientists in Switzerland have reported the first documented case of acute intermittent porphyria (AIP) caused by a mosaic mutation…
Plasma exchange — a procedure that involves replacing the liquid portion of blood, not blood cells — effectively eased motor…
Certain people with acute hepatic porphyria (AHP) living in British Columbia may now get full coverage of Givlaari…
A probiotic supplement led to improvements in blood sugar and insulin levels and increased heme production in a mouse model…